创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

LONG Jianling, XU Hui, ZENG Meng, YANG Lei, ZHENG Songbai. Research Progress in Diagnosis of Non-alcoholic Steatohepatitis[J]. Progress in Pharmaceutical Sciences, 2020, 44(3): 201-207.
Citation: LONG Jianling, XU Hui, ZENG Meng, YANG Lei, ZHENG Songbai. Research Progress in Diagnosis of Non-alcoholic Steatohepatitis[J]. Progress in Pharmaceutical Sciences, 2020, 44(3): 201-207.

Research Progress in Diagnosis of Non-alcoholic Steatohepatitis

  • Non-alcoholic fatty liver disease (NAFLD) is a chronic, non-communicable disease. In recent years, the prevalence and incidence of NAFLD have been increasing, while the age of onset has been decreasing. It has replaced chronic hepatitis B as the first chronic liver disease. This article reviews the research progress in the diagnosis of non-alcoholic steatohepatitis (NASH), and introduces the clinical history, pathological diagnosis and non-invasive diagnosis of NASH, in order to provide reference for clinical diagnosis of the disease.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return